These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6461763)

  • 41. Effects of a luteinizing hormone-releasing hormone analog and tamoxifen on the growth of an estrogen-induced prolactin-secreting rat pituitary tumor and its influence on pituitary gonadotropins.
    Lamberts SW; Uitterlinden P; Zuiderwijk-Roest JM; Bons-van Evelingen EG; de Jong FH
    Endocrinology; 1981 May; 108(5):1878-84. PubMed ID: 6452261
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of the efficacy for antitumor activity of the non-steroidal antiestrogens analog II and tamoxifen in 7,12-dimethylbenz[a] anthracene-induced rat mammary tumors.
    Pento JT; Magarian RA; King MM
    Cancer Lett; 1982; 15(3):261-9. PubMed ID: 6811128
    [No Abstract]   [Full Text] [Related]  

  • 43. Modification of the effect of a gonadoliberin analog on 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by hormone replacement.
    Rose DP; Pruitt B
    Cancer Res; 1979 Oct; 39(10):3968-70. PubMed ID: 113083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
    Zeng XZ; Yao ZX
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experimental study of combination medical endocrine therapy on DMBA-induced mammary tumor, with special reference to the effect of drug-dose on various factors].
    Kosaka A; Yamashita A
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):75-81. PubMed ID: 1530907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas.
    Iino Y; Takai Y; Sugamata N; Morishita Y
    Anticancer Res; 1992; 12(6B):2101-3. PubMed ID: 1295453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Goserelin acetate depot, LH-RH agonist; its properties and therapeutic effects in prostate cancer].
    Koga H; Naito S
    Nihon Rinsho; 2000 Jul; 58 Suppl():186-90. PubMed ID: 11022711
    [No Abstract]   [Full Text] [Related]  

  • 48. Induction of tamoxifen-dependent rat mammary tumors.
    Zimniski SJ; Warren RC
    Cancer Res; 1993 Jul; 53(13):2937-9. PubMed ID: 8319198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Luteinizing hormone-releasing hormone agonists for treatment of prostatic cancer].
    Gez E
    Harefuah; 1990 Apr; 118(8):483-6. PubMed ID: 2192959
    [No Abstract]   [Full Text] [Related]  

  • 50. Selective induction of hormone-dependent mammary adenocarcinoma in the rat.
    Huggins CB
    J Lab Clin Med; 1987 Mar; 109(3):262-6. PubMed ID: 3102655
    [No Abstract]   [Full Text] [Related]  

  • 51. Regression of rat mammary tumors effected by a gonadoliberin analog.
    DeSombre ER; Johnson ES; White WF
    Cancer Res; 1976 Oct; 36(10):3830-3. PubMed ID: 782692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [LHRH analogs--a new treatment in hormone-dependent tumors].
    Wilking N; Rutqvist LE; Theve T
    Lakartidningen; 1988 Feb; 85(8):620-3. PubMed ID: 3280927
    [No Abstract]   [Full Text] [Related]  

  • 53. Biodegradable sustained release formulation of the LH-RH analogue 'Zoladex' for the treatment of hormone-responsive tumours.
    Furr BJ; Hutchinson FG
    Prog Clin Biol Res; 1985; 185A():143-53. PubMed ID: 3162174
    [No Abstract]   [Full Text] [Related]  

  • 54. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins.
    Cho-chung YS; Doud FJ
    Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Luteinizing hormone-releasing hormone agonists in the treatment of breast cancer.
    Harvey HA
    Cancer Treat Res; 1988; 39():39-49. PubMed ID: 2908607
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hormonal treatment of breast tumor].
    Garcia Giralt E; Omodei Zorini C
    Clin Ter; 1990 Feb; 132(4):217-27. PubMed ID: 2140308
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of tamoxifen in the induction of hormone-independent rat mammary tumors.
    Fendl KC; Zimniski SJ
    Cancer Res; 1992 Jan; 52(1):235-7. PubMed ID: 1727383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The use of GNRH analogs in the treatment of hormone dependent tumors].
    Zakut H; Birkenfeld S; Krispin M; Naor Z; Zilberstein M
    Harefuah; 1984 May; 106(10):477-9. PubMed ID: 6381259
    [No Abstract]   [Full Text] [Related]  

  • 59. [Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH].
    Bertelli A
    Drugs Exp Clin Res; 1990; 16 Suppl():1-2. PubMed ID: 2081448
    [No Abstract]   [Full Text] [Related]  

  • 60. Regression of a pregnancy-dependent mouse mammary tumor (TP-DMT-4) by the antiestrogen, tamoxifen.
    Matsuzawa A; Yamamoto T
    Gan; 1979 Jun; 70(3):387-8. PubMed ID: 467901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.